Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism

Technology appraisal guidance
Reference number: TA261
Published: 25 July 2012

Venous thromboembolism (treatment and long term secondary prevention) - rivaroxaban: appendix A - matrix of stakeholders

Venous thromboembolism (treatment and long term secondary prevention) - rivaroxaban: appendix A - matrix of stakeholders

Venous thromboembolism (treatment and long term secondary prevention) - rivaroxaban: appendix A - matrix of stakeholders
12 May 2015
(99.61 Kb 29 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 11 May 2015